The Global Health Technologies Coalition (GHTC), of which ASTMH is a member, and Research!America are holding a special event on Friday, April 27, in Washington, D.C., titled, "Saving Lives and Creating Impact: Why Investing in Global Health Research Works."
The U.S. government has long played a role in research and development for new global health products that have transformed communities in the poorest countries in the world and saved the lives of millions. From the eradication of smallpox to the development of game-changing HIV drugs, American efforts have been central to many global health success stories throughout history. As infectious diseases continue to impact millions of people each year, the U.S. government has maintained this commitment and its position as the pre-eminent funder of global health R&D in the world.
In this constrained fiscal environment, new evidence on the benefits of global health R&D and the cost-effectiveness of past funding is critical. In addition, new actors are increasingly engaing in global health R&D, forming a key partnership across the public, philanthropic and private sectors. This event highlights the launch of a new report from the GHTC and Policy Cures that addresses these issues by analyzing the impact of past U.S. government investments, and reviewing the role of ongoing U.S. investments in global health R&D. A high-level panel representing the U.S. government, private industry and philanthropic sectors will discuss key issues in global health R&D in light of the report's findings.
Speakers representing key U.S. agencies, philanthropic organizations and private industry groups will be announced. To RSVP, please contact Nick Taylor at email@example.com or+1-202-822-0033.